Description
Données probantes
- Multiregional Rehabilitation Targeting the Cervical and Temporomandibular Regions in Chronic Neck Pain: A Randomized Controlled Trial.on 4 mai 2026
Physiotherapy Research International; 04/01/2026Background and Purpose: Non‐specific chronic neck pain (NSCNP) is highly prevalent and frequently associated with temporomandibular‐related impairments, yet rehabilitation programs commonly focus on a single anatomical region. Given the functional and biomechanical interconnections between the cervical spine and temporomandibular region, this study aimed to compare the short‐term effects of a cervical‐focused rehabilitation program with an integrated cervical–temporomandibular rehabilitation approach in individuals with NSCNP. Methods: In this single‐blind, randomized controlled trial, 42 adults with NSCNP were allocated to receive either cervical rehabilitation alone (45 min/session) or an integrated cervical–temporomandibular rehabilitation program (60 min/session), delivered five sessions per week for 4 weeks. Primary outcomes were pain intensity (VAS) and neck‐related disability (NDI). Secondary outcomes included posture, cervical range of motion, muscle endurance, and sleep quality. Outcomes were assessed at baseline and immediately post‐intervention. Results: Both groups demonstrated significant improvements in pain and disability following the intervention period (p < 0.001). Between‐group analyses showed greater short‐term reductions in pain intensity and neck‐related disability in the integrated rehabilitation group compared with cervical rehabilitation alone, with large effect sizes. More pronounced improvements were also observed across several secondary outcomes, including posture, cervical mobility, muscle endurance, and sleep quality. No adverse events were reported. Discussion: An integrated cervical–temporomandibular rehabilitation approach was associated with greater short‐term clinical improvements under a higher overall treatment dose than cervical‐focused rehabilitation alone in individuals with NSCNP. These findings suggest the potential clinical value of a multiregional treatment perspective; however, they should be interpreted with caution because the Cervical + TMJ group received a higher overall treatment dose, which precludes definitive attribution of the observed effects specifically to the temporomandibular‐directed components. Additionally, the findings are limited to immediate post‐intervention outcomes. Trial Registration: This study is registered at ClinicalTrials.gov with ID: NCT06005922(AN 193280719); ISSN: 13582267CINAHL Complete
- Psychosocial aspects, chronic pain, fatigue and quality of life in individuals with Stickler syndrome: A scoping review and a cross-sectional questionnaire study.on 4 mai 2026
Author Names: Velvin, Gry,Youssefian Blakstvedt, Taran,Olsson, Heidi,Langoy, Marit,Moller-Omrani, Christine,Svendal, Sturle,Austeng, Marit Erna Database Source: APA PsycInfo <April 2026 Week 3> Journal Title: Disability and Rehabilitation: An International, Multidisciplinary Journal Article Title: Psychosocial aspects, chronic pain, fatigue and quality of life in individuals with Stickler syndrome: A scoping review and a cross-sectional questionnaire study. Year: 2026 Issue: 4 Volume: 48 Abstract: Purpose: Stickler syndrome is a rare, hereditary connective tissue disorder characterized by visual, auditory, and musculoskeletal complications. Research on quality of life remains limited. This study aimed to: (i) explore existing literature on psychosocial aspects, pain, fatigue, and quality of life in individuals with Stickler syndrome, (ii) describe the impact of health complaints on daily living, contacts with healthcare- and social service systems and quality of life in a cohort of adults with Stickler syndrome. <ovid:br/>Methods: A combination of a systematic scoping review and a cross-sectional questionnaire study was utilized. The questionnaire included questions on demographics and health complaints, and several validated instruments: PROMIS-57, Satisfaction with Life Scale and LiSat-11. Only patients with a verified diagnosis were included. <ovid:br/>Results: Of 43 articles read, five studies were included. Four addressed pain and one examined quality of life in children. Chronic pain was a prevalent finding, impacting daily functioning and quality of life. In the questionnaire (n = 24), 92% reported chronic pain, along with fatigue, anxiety symptoms, and reduced quality of life. Still, participants reported education, employment, and family life. <ovid:br/>Conclusion: Individuals with Stickler syndrome experience health challenges affecting various aspects of life. Further studies are needed to develop evidence-based practice for this group. (PsycInfo Database Record (c) 2026 APA, all rights reserved)
- Hypnotic cognitive therapy for chronic pain in spinal cord injury: A randomized controlled trial.on 4 mai 2026
Author Names: Bombardier, Charles H,Mendoza, M. Elena,Thomas, Pavithra A,Barber, Jason K,Jensen, Mark P Database Source: APA PsycInfo <April 2026 Week 3> Journal Title: Neurology Article Title: Hypnotic cognitive therapy for chronic pain in spinal cord injury: A randomized controlled trial. Year: 2026 Issue: 8 Volume: 106 Abstract: Background and Objectives: Chronic pain is highly prevalent, disabling, and difficult to treat in people with spinal cord injury (SCI). Our objective was to determine whether hypnotic cognitive therapy (HYP-CT) significantly reduces average pain intensity. <ovid:br/>Methods: This single-blind, randomized, parallel-group trial investigated the efficacy of HYP-CT in treating moderate-to-severe chronic pain in community-residing adults with SCI. Participants were recruited nationwide through SCI organizations and randomized 1:1 to HYP-CT vs usual care (UC). We used computerized permuted block randomization with variable block sizes and stratified by sex and worst pain type. HYP-CT was delivered by a psychologist over the telephone or through Zoom and consisted of 6 weekly 60-minute sessions plus instructions to practice self-hypnosis daily independently by listening to session recordings. Controls were encouraged to continue current treatments or seek additional pain treatments. The primary outcome was average pain intensity assessed 4 times per week on a 0-10 numerical rating scale and averaged. The primary end point was at 6 weeks after randomization, with a follow-up assessment at 12 weeks. All outcomes were assessed through structured telephone interviews performed by blinded assessors. <ovid:br/>Results: A total of 127 participants were randomized to HYP-CT (n = 64) vs UC (n = 63). Forty-eight percent were treated over the telephone and 52% through Zoom. The group was 42% female, had a mean age of 51.3 years (15.4 years after SCI), and had a mean baseline pain intensity of 5.93. The worst pain was neuropathic in 57% of cases. The primary outcome, average pain intensity, decreased more in the HYP-CT group compared with UC controls at 6 (-0.55, 95% CI -1.04 to -0.06) and 12 (-0.79, 95% CI -1.28 to -0.29) weeks. Depression declined significantly more in the HYP-CT vs UC groups at 6 and 12 weeks. Planned exploratory analyses […]
- Association between state cannabis laws and opioid outcomes: A systematic reviewon 4 mai 2026
Drug Alcohol Depend. 2026 Apr 17;284:113167. doi: 10.1016/j.drugalcdep.2026.113167. Online ahead of print.ABSTRACTBACKGROUND: Through increasing cannabis availability, state cannabis legalization has been posited as one potential solution to the opioid crisis by providing an alternative to long-term opioid use for treating chronic pain. Forty U.S. states have legalized cannabis for medical use and 25 for recreational use. We systematically reviewed the literature to investigate the relationship of state medical and recreational cannabis legalization (MCL and RCL, respectively) to rates of opioid prescriptions, nonmedical use, opioid use disorder (OUD), opioid-related hospitalizations and emergency department visits, and overdose deaths.METHODS: We searched EconLit, EMBASE, MEDLINE, and Web of Science Core Collection for English-language studies published through 10/21/25 that estimated MCL or RCL enactment effects on opioid outcomes compared to states that did not enact such laws. This study is registered with PROSPERO, CRD42023416119.FINDINGS: Of 43 eligible studies, 18 investigated MCL, 11 investigated RCL, and 14 investigated both. Findings on MCL, RCL and opioid prescribing were mixed. No study found decreases in non-medical opioid use after MCL enactment; only one study found decreased non-medical use after RCL enactment. No studies found that MCL or RCL decreased OUD. MCL enactment was associated with lower opioid overdose mortality rates in earlier but not more recent studies; studies of RCL and opioid overdose fatalities had inconsistent results.INTERPRETATIONS: The mixed study findings suggest that MCL and RCL are just two factors in a complex set of influences on opioid outcomes that require further study. Meanwhile, cannabis legalization should not be considered an effective policy for curbing the opioid epidemic.PMID:42061001 | DOI:10.1016/j.drugalcdep.2026.113167
- Precision Pain Management in Interventional Radiology: A Systematic Review :on 4 mai 2026
Galen Med J. 2025 Jul 29;14:e3922. doi: 10.31661/gmj.vi.3922. eCollection 2025.ABSTRACTChronic pain, as a complex and individual phenomenon, still represents a significant issue in both the acute and chronic contexts. This study aimed to investigate the current state of pain management in IR procedures and identify potential areas for improvement in the standardization of pain management protocols. IR approaches are less invasive and focus on individualized treatment targeting the cause of pain, especially in chronic pain states. Precision pain medicine aims to tailor treatment plans based on algorithms grounded in evidence to address the needs of patients. This systematic review aims to assess the effectiveness of IR in precision pain management by analyzing its techniques, safety, and clinical outcomes. In light of the existing literature, this review aims to fill the knowledge gap, call for protocol harmonization, and demonstrate how IR can contribute to patient-centered care. The results are expected to contribute to the knowledge base, inform future research and clinical practice, and improve patients' quality of life with multiple pain conditions.PMID:42038876 | PMC:PMC12877327 | DOI:10.31661/gmj.vi.3922
- Management of Gynaecological Chronic Pelvic Pain in the Emergency Setting- A Scoping Reviewon 4 mai 2026
Aust N Z J Obstet Gynaecol. 2026 Apr;66(2):e70132. doi: 10.1111/ajo.70132.ABSTRACTBACKGROUND: Gynaecological chronic pelvic pain (CPP) has a high prevalence among adult women. This pain can be debilitating and life-impacting, affecting quality of life across all dimensions of health. Many barriers to specialised care exist, leading women to rely on unscheduled general care like emergency departments or in the out-of-hospital.OBJECTIVE: The review aimed to investigate evidence regarding pain management for women presenting to acute, non-specialist settings for gynaecological CPP. Secondary aims were to identify areas of suboptimal care and potential for improvement of patient outcomes.METHODS: A scoping review was conducted using the Joanna Briggs Institute scoping review framework with the PRISMA extension. Academic and grey literature were searched.RESULTS: Initially, 1563 records were identified, with 50 from grey literature and 801 from citation screening. Nineteen were included for descriptive analysis. Key themes were pharmacological agents, holistic care and ongoing care. Appraisal of the literature showed varying quality.CONCLUSION: This scoping review highlights the need to define clinicians' roles in managing gynaecological CPP exacerbations in acute, non-specialist settings. It identifies gaps in best-practice pain assessment, management and clinician education, with guidelines and recommendations often of poor quality. Effective CPP management requires a multidisciplinary and biopsychosocial approach and, despite limitations, clinicians can enhance knowledge and practice scope to improve patient outcomes.PMID:42007586 | DOI:10.1111/ajo.70132
- Is treating both chronic pain and trauma-related symptoms at the same time effective? A systematic review and meta-analysis of psychological interventionson 4 mai 2026
Pain. 2026 Apr 7. doi: 10.1097/j.pain.0000000000003967. Online ahead of print.ABSTRACTThere is a large proportion of people living with chronic pain who also experience posttraumatic stress symptoms; however, there is no current standard treatment for addressing these mutually maintaining conditions. The aim of this systematic review and meta-analysis was to examine the efficacy of psychotherapeutic interventions for adults with chronic pain and trauma symptoms, where the effects of psychotherapy could be isolated. Systematic searches were conducted in 5 databases (MEDLINE, Embase, the Cochrane Central Register of Controlled Trials, the Cochrane Database of Systematic Reviews, and APA PsycINFO) until October 8, 2025. Randomized controlled trials were included if they had a psychological intervention component addressing chronic pain and/or trauma exposure/trauma-related symptoms. Methodological quality was assessed using the Cochrane risk of bias tool. Eighteen studies met our inclusion criteria with 61% having high risk of bias. The results revealed that psychological interventions were found to significantly reduce pain intensity (SMD = 0.34 [95% CI, 0.10-0.58]), pain interference (SMD = 0.20 [95% CI, 0.004-0.39]), and trauma-related symptoms (SMD = 0.36 [95% CI, 0.22-0.51]), as compared with controls, immediately after the interventions with sustained effects 3 to 6 months postintervention (SMD = 0.40 [95% CI, 0.29-0.52], SMD = 0.20 [95% CI, 0.05-0.36], and SMD = 0.38 [95% CI, 0.20-0.55]). Our findings suggest that psychological interventions may effectively reduce pain and trauma symptoms in populations with overlapping pain and trauma-related presentations, but larger, rigorous trials are needed to identify mechanisms of change and determine which interventions work best for whom.PMID:41973679 | DOI:10.1097/j.pain.0000000000003967
- EXPRESS: Pain Variability in Chronic Pain: A Systematic Reviewon 4 mai 2026
Mol Pain. 2026 Apr 9:17448069261439609. doi: 10.1177/17448069261439609. Online ahead of print.ABSTRACTOBJECTIVE: To present the first systematic review on the empirical evidence for variations in intraindividual pain intensity in patients with long-term pain conditions.METHODS: The search was conducted on Medline and included prospective longitudinal non-interventional studies done on adult human subjects with chronic pain conditions linked to nociplastic pain mechanisms. Abstract screening and full-text review were performed by 2 independent reviewers. A third reviewer was consulted in case of disagreement.RESULTS: Of the 1195 results, 13 studies fulfilled the eligibility criteria as determined by abstract screening and full-text review performed by 2 independent reviewers. Studies included patients with fibromyalgia, low back pain, temporomandibular disorder and, because of the growing evidence for central sensitization, osteoarthritis. Findings showed consistent evidence of intraindividual pain variability in patients with nociplastic pain, regardless of diagnosis. In several studies, it was possible to cluster patients based on degree of pain variability.CONCLUSIONS: Our findings provide evidence of intraindividual variability in pain intensity in patients with pain conditions that includes nociplastic pain mechanisms, regardless of precise diagnosis. Preliminary evidence suggests that degree of intraindividual pain variability may be associated with measures of clinical relevance, including mental health, fatigue, physical activity level, and drug and placebo response.PMID:41953999 | DOI:10.1177/17448069261439609
- Psychological determinants and predictors of outcomes in spinal cord stimulation: a systematic reviewon 4 mai 2026
Pain Rep. 2026 Apr 3;11(3):e1429. doi: 10.1097/PR9.0000000000001429. eCollection 2026 Jun.ABSTRACTSpinal cord stimulation (SCS) has been proven to be an effective therapy for chronic persistent pain conditions. In addition to somatic and technical variables, the effectiveness of this therapy is also influenced by psychological factors. Despite the growing number of studies, there is currently no consensus on which factors predict outcomes of SCS treatment. The existence of this knowledge gap underscores the need for a systematic review to consolidate the current knowledge about the role of psychological factors in the efficacy of SCS. A comprehensive literature search was conducted for this systematic review. The protocol for this review was registered at the International Database of Systematic Reviews (PROSPERO, CRD42024572349). The data from the included studies were synthesized using an Excel overview. The Newcastle-Ottawa Scale was used to evaluate the quality of the included studies. After duplicate removal, 1733 studies were identified; 29 studies met the inclusion criteria. The multiple questionnaires used in the included articles to measure psychological factors were divided into 7 domains: fear/anxiety, depressive feelings, catastrophizing, sleep, social functioning, pain, and psychiatric problems. The results were subjected to analysis on a per-domain basis. The domains of fear/anxiety, catastrophizing, and depressive feelings were classified as partially predictive, meaning that the reviewed articles provided mixed evidence regarding their predictive value for SCS outcome. The remaining 4 domains were either inconclusive or nonpredictive of SCS outcome. These psychological factors should not be used in isolation for selection, but they can contribute to a comprehensive assessment before SCS.SIGNIFICANCE STATEMENT: In current practice, the predictive value of psychological factors within the scope of outcome in Spinal Cord Stimulation therapy is not always clear. This systematic review aimed to synthesize existing evidence to determine the extent to which psychological factors influence both short- and long-term SCS outcomes, thereby informing clinical decision-making and future research.PMID:41948474 | PMC:PMC13052926 | DOI:10.1097/PR9.0000000000001429
- Spinal Cord Stimulation for Pain Management Following Spinal Cord Injury: A Systematic Reviewon 4 mai 2026
J Pain Res. 2026 Mar 30;19:573333. doi: 10.2147/JPR.S573333. eCollection 2026.ABSTRACTPURPOSE: Chronic pain affects more than 80% of individuals with spinal cord injury (SCI), profoundly impairing mobility, rehabilitation, and quality of life. Conventional pharmacologic and non-pharmacologic treatments often fail to achieve adequate relief. Spinal cord stimulation (SCS) has emerged as a potential neuromodulatory therapy for neuropathic pain; however, its role in SCI remains insufficiently defined.PATIENTS AND METHODS: A systematic review was conducted in accordance with PRISMA 2020 guidelines and registered with PROSPERO (CRD42024541622). Comprehensive searches of PubMed, Embase, Web of Science, and the Cochrane Library were performed through April 2024. Eligible studies evaluated SCS for chronic pain in adults with SCI and reported validated pain or patient-reported outcomes. Screening, eligibility assessment, and data extraction were performed in duplicate. Risk of bias and certainty of evidence were evaluated using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework and the MethodologicAl STandards for Epidemiological Research (MASTER) tool.RESULTS: From 1064 records, 10 studies involving 43 participants met inclusion criteria. Most were case reports or small case series, with one prospective cohort study. All studies reported pain improvement after SCS using heterogenous outcome formats; minor adverse events were reported in 3 studies, and the remaining 7 studies reported none. The overall certainty of evidence was rated very low due to small sample sizes, heterogeneity in study design, and methodological limitations. Three ongoing clinical trials evaluating SCS for pain in SCI were also identified.CONCLUSION: Preliminary, very low-certainty evidence indicates that SCS may be a promising option for chronic pain after SCI, with limited reported complications in the available literature. Higher-quality studies are required to confirm benefit, characterize risks, and guide patient selection and programming.PROSPERO REGISTRATION NUMBER: CRD42024541622.PMID:41938223 | PMC:PMC13048227 | DOI:10.2147/JPR.S573333
- Sex Differences and Psychological Assessments in Chronic Pain: A Systematic Review and Meta-Analysison 4 mai 2026
Clin Neuropsychiatry. 2026 Apr;23(2):193-204. doi: 10.36131/cnfioritieditore20260207.ABSTRACTOBJECTIVE: Mental illnesses often coexist with pain, forming a vicious cycle that exacerbate disabilities. Existing sex biases and conflicting study results remain contentious. The primary outcome of this systematic review and meta-analysis is to compare different psychological assessment scores across sexes in chronic pain populations.METHOD: We performed a systematic review of the association of mental health outcomes among different sexes in the chronic pain population based on a comprehensive search of PubMed, ScienceDirect, ProQuest, and EBSCOhost. A meta-analysis was conducted based on available data to clarify the association between psychological test results and sex differences. Joanna Briggs Institute (JBI tool) was used to verify the quality of the evidence. The Standardized Mean Differences (SMD) with a confidence interval (CI) of 95% were used to determine the association.RESULTS: Nine cross-sectional studies were included in the meta-analysis (3,003 participants), comprising four anxiety and eight depression assessments. The JBI tool rated all studies as high quality. The analysis showed that females had significantly lower anxiety scores (SMD - 0.10; p = 0.03) with chronic pain. The depression scores did not differ between sexes (SMD 0.13; p = 0.20).CONCLUSIONS: This study demonstrated that females had significantly lower anxiety scores than males in chronic pain populations, with no differences in depression. Therefore, care should unbiasedly address the pain experience and mental health in males, which is often underrecognized among chronic pain sufferers.PMID:42052223 | PMC:PMC13116280 | DOI:10.36131/cnfioritieditore20260207
- Shedding light on pain management: a translational systematic review of light therapy for the treatment of chronic painon 4 mai 2026
EBioMedicine. 2026 Apr 28:106251. doi: 10.1016/j.ebiom.2026.106251. Online ahead of print.ABSTRACTBACKGROUND: Pharmacological options remain the primary approach for chronic pain management; however, alternative multimodal interventions are necessary. Light therapy, which can modulate circadian (24-h) rhythms, has been increasingly explored as a potential treatment for chronic pain; yet, its efficacy and underlying mechanisms remain unclear. This systematic review summarises evidence on photoreceptor-mediated light therapy for chronic pain in clinical and preclinical studies.METHODS: Four databases (Ovid MEDLINE, EMBASE, PsycINFO, and Web of Science) were searched for studies published up to August 29, 2025. Eligible studies evaluated the effects of light therapy on chronic pain outcomes; risk of bias was assessed using the Cochrane tool for clinical populations and the SYRCLE tool for animal models. Studies involving light acting directly on the site of injury or skin were excluded. Outcomes related to pain were synthesised descriptively due to heterogeneity in study designs and interventions. This review was registered with the PROSPERO database (CRD42023429231).FINDINGS: Of 7757 studies screened, 18 studies were included (11 clinical and 7 preclinical). Overall, light therapy was associated with improvements in pain-related outcomes. However, the findings were inconsistent, particularly when dim-light (low intensity illumination) conditions were used as controls. Evidence was limited by methodological heterogeneity, unclear risk of bias in most preclinical studies, and incomplete assessment of circadian rhythms.INTERPRETATION: Light therapy may represent a promising non-pharmacological intervention for chronic pain. Current evidence is insufficient to draw firm conclusions regarding efficacy or underlying circadian mechanisms. Further well-designed studies incorporating circadian assessments and individual pain profiles are needed.FUNDING: This work was supported by the Canadian Institutes of Health Research (PJT-497592 and MYG-191676).PMID:42055834 | DOI:10.1016/j.ebiom.2026.106251
- Comparison of the efficacy of hyaluronic acid vs corticosteroids, platelet-rich plasma, and physical therapy in chronic shoulder pain:: a systematic review and a frequentist network metanalysison 4 mai 2026
Arch Phys Med Rehabil. 2026 Apr 30:S0003-9993(26)00688-X. doi: 10.1016/j.apmr.2026.04.026. Online ahead of print.ABSTRACTOBJECTIVE: To compare the effectiveness of injected low- and high-molecular-weight hyaluronic acid (HA-LMW, HA-HMW) vs corticosteroids (CCS), placebo- or physical therapy (PT), on pain at rest (Prest), at night (Pnight), and during activity (Pact), range of motion (ROM), functional status (FS), and quality of life (QoL) in patients with chronic Sp, at 3 (3mo) and 6 months (6mo) follow-up.DATA SOURCES: A systematic literature search was conducted through October 2024 across MEDLINE, Embase, and Cochrane CENTRAL.STUDY SELECTION: Fourteen studies were included: 12 randomized controlled trials and 2 prospective cohort studies that compared at least two of the treatments of interest in adults with chronic shoulder pain (Sp).DATA EXTRACTION: Two reviewers independently extracted data related to the outcomes.DATA SYNTHESIS: A frequentist network meta-analysis with mean differences (MD) and standardized mean differences (SMD) was performed; p<0.05 was statistically significant. PT reduced Prest compared to HA-HMW (MD = -3.02, p<0.01 at 3mo; MD = -2.08, p<0.01 at 6mo) and HA-LMW (MD = -1.95, p<0.01 at 6mo) in tendinopathy. PT showed greater reduction than both HA formulations in Pnight and Pact at 6mo in tendinopathy. No differences were observed between HA-HMW and HA-LMW for pain outcomes considering shoulder different diseases. HA improved adduction and internal rotation at 3mo considering shoulder different disease; PT was superior for flexion and external rotation at 6mo in tendinopathy. Stratified by pathology, HA-HMW showed moderate efficacy in adhesive capsulitis. HA-HMW improved FS compared to HA-LMW at 3mo. CCS improved abduction in shoulder disease due to different causes.CONCLUSIONS: PT provides greater pain control for Sptendinopathy, particularly for Prest, Pnight, and Pact at both 3mo and 6mo. HA may contribute to improved QoL and specific ROM parameters. Further high-quality studies are required to consolidate these findings.PMID:42069289 | DOI:10.1016/j.apmr.2026.04.026
Pratiques innovantes
- Riluzole in Acute Spinal Cord Injury Study with the Bayesian Approach to Overcome Small Sample Size & Inter-subject Variabilityon 4 mai 2026
Author Names: Park J.,Nguyen A.,Wu L.,Toups E.,Harrop J.,Guest J.,Schmitt K.,Fehlings M.,Grossman R.,Chow D. Database Source: Embase Weekly Updates Journal Title: Clinical Pharmacology in Drug Development Article Title: Riluzole in Acute Spinal Cord Injury Study with the Bayesian Approach to Overcome Small Sample Size & Inter-subject Variability Year: 2023 Issue: Supplement 1 Volume: 12 Abstract: Statement of Purpose, Innovation or Hypothesis: Spinal cord injury (SCI) is a life-threatening and severely debilitating condition that results in permanent disabilities along with chronic pain, psychological trauma and social stigma. According to the 2013 American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) guidelines, currently, there is no standardized treatment for SCI. One of the main reasons for this delayed drug development in SCI stems from extreme inter-subject variability, which challenges the consistent pharmacokinetic (PK)/pharmacodynamic (PD) data analysis with a conventional approach. Furthermore, having a small population of SCI patients makes small sample sizes inevitable. Additionally, enrolling patients for PK study is challenging given the critical condition of patients upon hospital admission. To overcome the small sample size and inter-subject variability, we utilized the Bayesian approach for our Phase II/III clinical trial (NCT01597518), Riluzole in Acute Spinal Cord Injury Study (RISCIS). The Bayesian estimation is a powerful tool to assess both precision and variance in PK, by using conditional probability. It weighs the known prior knowledge ('prior') of a PK parameter and new data ('evidence'), to estimate a new probability ('posterior') for predicting its PK parameters. This updated probability then serves as the new prior probability as additional data becomes available, effectively allowing us to adjust our understanding in response to accumulating information. Our hypothesis is that the Bayesian approach improves in estimating the PK (Table present) parameters within the small-sized and heterogeneous RISCIS patients. Description of Methods and Materials: Patient data were obtained from RISCIS, a multi-center, randomized, placebo-controlled, double-blinded clinical trial. Patients in the treatment group […]
- Effect of Peri-Operative Music Therapy on Anxiety, Pain Catastrophising, and Pain in Chronic Pain Patients Undergoing Interventional Pain Procedures - A Randomised Controlled Trialon 4 mai 2026
Author Names: anonymous Database Source: Embase Clinical Trials Journal Title: clinicaltrials.gov Article Title: Effect of Peri-Operative Music Therapy on Anxiety, Pain Catastrophising, and Pain in Chronic Pain Patients Undergoing Interventional Pain Procedures - A Randomised Controlled Trial Year: 2025 Issue: Volume: Abstract: Brief Summary,This study aims to find out whether listening to music before, during, and after pain procedures can help reduce anxiety, pain catastrophising, and acute pain in patients with chronic pain. Music therapy may provide a simple, safe, and non-drug way to help patients relax and feel more comfortable. In this study, adult patients with chronic pain who are scheduled for interventional pain procedures at Singapore General Hospital will be randomly assigned to one of two groups. One group will listen to self-selected music through headphones and speakers before, during, and after the procedure. The other group will receive standard care without music. Researchers will measure anxiety, pain catastrophising, and pain levels before and after the procedure using validated questionnaires. The main outcome will be the level of anxiety after the procedure. Other outcomes include pain catastrophising scores, pain scores during local anaesthetic injection, and overall patient satisfaction. This study will help determine if music therapy can be routinely used to improve comfort and emotional well-being for patients undergoing interventional pain procedures.,Detailed Description,This is a single-centre, randomised controlled trial conducted at the Singapore General Hospital Pain Management Centre. The study investigates whether peri-operative music therapy can reduce anxiety, pain catastrophising, and pain in patients with chronic pain undergoing interventional pain procedures in the ambulatory setting. A total of 110 adult participants (aged 21 years and above) with chronic pain lasting at least 3 months and scheduled for interventional pain procedures will be enrolled. Participants will be randomised in a 1:1 ratio to either the music therapy group or the control group using a computer-generated block randomisation sequence with sealed opaque envelopes. Intervention group: Participants will listen to self-selected music from curated playlists […]
- Skill-Based Virtual Reality Therapy in High-Impact Chronic Pain: 2-Year Follow-Up Results From a Secondary Analysis of a Randomized Controlled Trialon 4 mai 2026
Author Names: Maddox T.,Sackman J.,Bonakdar R.,Maddox R.,Darnall B.D. Database Source: Embase Daily Updates Journal Title: Journal of Medical Internet Research Article Title: Skill-Based Virtual Reality Therapy in High-Impact Chronic Pain: 2-Year Follow-Up Results From a Secondary Analysis of a Randomized Controlled Trial Year: 2026 Issue: Volume: 28 Abstract: Background: High-impact chronic pain (HICP) involves substantial interference in functioning, affects 8.5% of the population, and leads to higher health care costs relative to low-impact chronic pain (LICP). Behavioral interventions such as virtual reality (VR) offer scalable and accessible treatment, but testing is needed to ensure durable effectiveness in HICP. We conducted a secondary analysis of the largest real-world dataset for a therapeutic skill-based VR vs a sham VR control to test treatment efficacy in HICP vs LICP. Relative to LICP, we found significantly larger (and clinically meaningful; ie, >=2 points) pain interference and pain intensity reductions for HICP at end of treatment and 1 year posttreatment. End-of-treatment reduction in pain interference reclassified 70% (114/163) of participants with HICP as LICP, and this improvement held at 1 year posttreatment (104/155, 67%). <br/>Objective(s): This study examined the effectiveness of a 56-session skill-based VR therapy in HICP at 2 years posttreatment and compared the effects with those on LICP. <br/>Method(s): We conducted a secondary analysis of the skill-based VR sample (536/1067, 50.2%) at 2 years posttreatment from a randomized controlled trial involving an in-home chronic low back pain sample that was recruited and tested online and was diverse (female: 411/536, 77%; non-White individuals: 166/536, 31%; high school or lower educational level: 102/536, 19%; mean age 50.8 years) and had clinically severe pain at baseline (intensity=6.6; interference=6.2; 42% with severe or complete disability). Focusing on the skill-based VR participants (536/1067, 50.2%) and using a validated approach, we classified participants at baseline as either HICP (baseline Brief Pain Inventory pain interference score>7) or LICP (baseline Brief Pain Inventory pain interference score<7). Clinical effectiveness was examined using a general linear […]
- Meta-analytic Evidence for Four Amplifier Loops in Chronic Pain Chronification: Development of the Pain Amplifier Loop Framework (PALF) Risk Scoreon 4 mai 2026
Author Names: Arranz-Duran J. Database Source: Embase Preprint Journal Title: medRxiv Article Title: Meta-analytic Evidence for Four Amplifier Loops in Chronic Pain Chronification: Development of the Pain Amplifier Loop Framework (PALF) Risk Score Year: 2026 Issue: Volume: Abstract: Objective: To quantify the effect size of four biopsychosocial amplifier loops on chronic pain outcomes through systematic review and meta-analysis, and to develop a logistic regression-based risk stratification tool for interventional pain medicine. <br/>Method(s): We searched PubMed, Scopus, and Cochrane Library through March 2026 for studies reporting adjusted odds ratios for associations between (1) sleep disturbance, (2) pain catastrophizing, (3) metabolic/inflammatory markers, (4) preoperative opioid use/polypharmacy, and chronic pain chronification or treatment failure. Random-effects meta-analyses (DerSimonian-Laird) were performed for each loop. Effect sizes were translated into a composite logistic regression model - the Pain Amplifier Loop Framework (PALF) - using ln(OR) as first-order coefficient approximations. The neurobiological convergence of all four loops on TLR4-mediated microglial activation was examined. <br/>Result(s): Forty-four studies (>500,000 participants) were included. Pooled odds ratios were: sleep disturbance OR=1.80 (95% CI 1.65-1.96; k=16; I<sup>2</sup>=51%), pain catastrophizing OR=2.11 (95% CI 1.71-2.61; k=8; I<sup>2</sup>=0%), metabolic/fat mass OR=2.02 (95% CI 1.32-3.09; k=7), preoperative opioid use OR=4.48 (95% CI 2.87-6.97; k=6; I<sup>2</sup>=84%), and opioid-benzodiazepine co-prescription OR=2.62 (95% CI 1.76-3.89; k=7; I<sup>2</sup>=79%). All four loops converge on TLR4/NF- B microglial signaling. The PALF model produces a Systemic Load Score (Z) and probability of interventional failure P=1/(1+e<sup>-Z</sup>), enabling stratification into low (<0.30), moderate (0.30-0.60), and high (>=0.60) risk categories. <br/>Conclusion(s): Four amplifier loops independently and substantially increase chronic pain risk, with the iatrogenic/opioid loop showing the largest effect. The PALF provides a transparent, clinically actionable risk score requiring prospective […]
- Evaluation of PainWaive: A consumer-grade EEG headset for remotely delivered neurofeedback and monitoring in chronic painon 4 mai 2026
Author Names: Chowdhury N.S.,Rawsthorne J.,Hesam-Shariati N.,Quide Y.,McIntyre A.,Restrepo S.,Chen K.,Lin C.-T.,John T.N.,Middleton J.W.,Craig A.,Jensen M.P.,McAuley J.,Gustin S.M. Database Source: Embase Preprint Journal Title: medRxiv Article Title: Evaluation of PainWaive: A consumer-grade EEG headset for remotely delivered neurofeedback and monitoring in chronic pain Year: 2026 Issue: Volume: Abstract: Affordable home-based electroencephalography (EEG) headsets could widen access to EEG assessment, but require rigorous validation before research or clinical use. Here, we evaluated a custom-developed 2-channel sensorimotor headset (PainWaive) intended for remote neurofeedback and longitudinal monitoring in chronic pain. Eighty participants (47 female; mean age 24.0 years, SD 7.9) completed two resting-state sessions with PainWaive and a research-grade 64-channel EEG system (LiveAmp), under eyes-open (EO) and eyes-closed (EC) conditions. Alpha, beta and theta power and peak alpha frequency (PAF) were derived from homologous sensorimotor channels (C1/C2). Relative reliability was quantified with intraclass correlation coefficients (ICCs), absolute reliability with SEM%, and cross-device consistency with between-device ICCs and Pearson correlations of overall spectral shape. ICCs/correlations were interpreted using pre-specified thresholds: fair 0.20-0.39, moderate 0.40-0.59, good 0.60-0.79, excellent >=0.80. PainWaive and LiveAmp showed comparable absolute reliability across metrics (similar SEM%). Under EC, PainWaive reliability was excellent for alpha (0.81), theta (0.85) and PAF (0.94), and good for beta (0.72). Under EO, reliability was excellent for alpha (0.82), good for beta and PAF (0.61-0.72), and moderate for theta (0.59). Spectral-shape correlations between devices were excellent (r>0.90). Cross-device ICCs were good under EC for alpha/theta/PAF (ICC=0.66-0.77) though fair for beta (0.35). Under EO, ICCs were good for alpha (0.62), moderate for PAF (0.53), and fair for beta/theta (0.26-0.32). To assess performance under real-world use, we additionally analysed 2 clinical samples of individuals (total n = 8) with chronic pain who each completed 20 home-based neurofeedback sessions using PainWaive (160 sessions total). Within-session stability was […]
- Low-intensity transcranial focused ultrasound engages parvalbumin-positive GABAergic interneurons in a humanized mouse model of chronic pain: from electrophysiology to cellular investigationon 4 mai 2026
Author Names: Kim M.G.,Yeh C.-Y.,Gao H.,Lee K.,Gupta K.,He B. Database Source: Embase Weekly Updates Journal Title: Journal of Neural Engineering Article Title: Low-intensity transcranial focused ultrasound engages parvalbumin-positive GABAergic interneurons in a humanized mouse model of chronic pain: from electrophysiology to cellular investigation Year: 2026 Issue: 2 Volume: 23 Abstract: Objective. Low-intensity transcranial focused ultrasound (tFUS) offers high spatial specificity and deep brain penetration, representing a promising non-invasive approach for modulating brain activity and behavior. Although emerging studies indicate that tFUS can modulate pain-related behaviors in rodents and humans, the underlying network-level and cellular mechanisms remain unknown. This study investigates the effects of tFUS neuromodulation on inhibitory neural circuits in a humanized mouse model of chronic pain, integrating electrophysiological, molecular, and histological analyses across a cohort of 50 animals, including wild-type controls. Approach. A 128-element random array transducer was used to precisely target the pain-processing brain circuit, while a non-invasive and flexible 30-channel electroencephalography electrode was applied to record local evoked responses, topographical activity, and global excitation and inhibition dynamics, which were further validated by optogenetics experiments. Cellular-level modulation and safety outcomes were evaluated through blinded histological examination. Main results. We found that tFUS produced robust modulation of local and global brain activity, characterized by suppression of local theta oscillations and enhancement of network-level inhibitory dynamics. These electrophysiological patterns aligned with those observed during optogenetic activation of parvalbumin (PV) interneurons. Immunohistochemistry further showed significant increases in inhibitory neuronal markers, including elevated expressions of glutamate decarboxylase 67 and PV. Blinded histological assessment confirmed the absence of tissue damage, supporting the safety of the stimulation paradigm. Significance. These findings demonstrated that tFUS stimulation non-invasively engages PV GABAergic inhibitory circuits in a chronic pain mouse model, providing mechanistic […]
- Ecological Momentary Assessments of daily pain experiences in bothersome and high-impact chronic painon 4 mai 2026
Author Names: Walentynowicz M.,Junghaenel D.U.,Mackey S.C.,Korff M.V.,Stone A.A. Database Source: Embase Preprint Journal Title: medRxiv Article Title: Ecological Momentary Assessments of daily pain experiences in bothersome and high-impact chronic pain Year: 2026 Issue: Volume: Abstract: High-impact chronic pain (HICP), defined as persistent pain that substantially limits daily activities, affects millions of adults and poses a public health challenge. Yet relatively little is known about how HICP manifests in people's daily lives. To address this gap, this study used the comprehensive Ecological Momentary Assessment of pain (cEMAp) to assess pain-related experiences four times per day over 7 days in individuals with chronic low back pain. Based on the classification using the Graded Chronic Pain Scale-Revised, we compared individuals with HICP (n = 66) with those in the next most severe pain category, bothersome chronic pain (n = 41), defined as having similar pain frequency but less frequent interference with daily activities. On each prompt, participants completed 2-hour assessments of pain intensity, interference, catastrophizing, behaviors, coping strategies, and pain characteristics. In line with prior research, both groups reported similar pain intensity levels, but the HICP group reported more frequent interference with physical, mental, and social activities. There were no group differences in daily mood or catastrophizing. Exploratory analyses suggested that many daily experiences were similar across groups, with differences observed in selected pain qualities, coping strategies, and pain behaviors. Additional analyses of response distributions showed some similarity across groups in many experiences. Overall, although individuals with HICP on average experience higher pain interference in daily life, levels of many day-to-day experiences are similar between the two groups. Data obtained with cEMAp complement traditional retrospective assessment by providing a detailed view of chronic pain in everyday life.<br/>Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
- Alterations of static and dynamic functional connectivity of the nucleus accumbens subregions may be associated with chronic process of migraine: a resting-state fMRI study.on 4 mai 2026
Journal of Headache & Pain; 04/02/2026Background: The nucleus accumbens (NAc) plays an important role in the chronic pain process and consists of core and shell subregions with distinct connectivity patterns. However, their roles in migraine progression remain unclear. This study explored static and dynamic functional connectivity (FC) patterns of NAc subregions across healthy controls (HCs), patients with episodic migraine (EM) and patients with chronic migraine (CM). Methods: 97 participants were enrolled: 70 migraine patients (24 EM, 46 CM) and 27 HCs. All underwent functional magnetic resonance imaging on a GE 3.0T system. Demographic and clinical characteristics were collected. The NAc core and shell were defined as ROIs, and static and dynamic seed-based FC analyses were performed across groups. Partial correlations between FC values and clinical variables were conducted. Significant static FC and dynamic FC were selected through multivariable logistic regression. Receiver operating characteristic curves were used to assess their diagnostic performance for distinguishing CM patients. Results: Compared with HCs, EM showed increased sFC between the right NAc core and right supplementary motor area (SMA), whereas CM exhibited decreased sFC, particularly between the left NAc shell and the left fusiform gyrus and between the right NAc core and the left cerebellum crus II. Relative to EM, CM showed reduced sFC mainly between the left NAc shell and the bilateral precentral gyrus and right superior frontal gyrus (SFG), and between the right NAc core and right SMA, right inferior frontal gyrus, and left inferior temporal gyrus (ITG). The dFC analysis revealed decreased connectivity between the left NAc shell and left precentral gyrus and right SFG, and between the right NAc core and left SMA. Reduced sFC between the right NAc core and left ITG and dFC between the left NAc shell and right SFG effectively distinguished CM from EM. The combined FC calculated from sFC and dFC further improved discrimination (AUC = 0.919). Conclusions: NAc subregions in CM showed reduced connectivity with multiple brain regions, mainly in sensorimotor, executive control, and default mode networks. Significant sFC and dFC of the NAc subregions may serve as potential imaging biomarkers for CM.(AN 192873749); ISSN: 11292369CINAHL Complete
- Cognitive bias modification for individuals with opioid use disorder and chronic pain did not predict changes in clinical outcomes.on 4 mai 2026
Author Names: Wolkowicz, Noah R,Pittman, Brian,Schrader, Shannon W,Wesolowicz, Danielle M,Sofuoglu, Mehmet,Heapy, Alicia A,Maclean, R. Ross Database Source: APA PsycInfo <April 2026 Week 3> Journal Title: Journal of Studies on Alcohol and Drugs Article Title: Cognitive bias modification for individuals with opioid use disorder and chronic pain did not predict changes in clinical outcomes. Year: 2026 Issue: 2 Volume: 87 Abstract: Objective: Attentional bias, defined as the preferential focus on personally salient-compared with neutral-cues, has a hypothesized link to substance use disorders and chronic pain. Although growing research demonstrates that cognitive bias modification (CBM) can alter attentional biases, evidence is lacking to assess the extent to which such alterations predict changes in clinical symptoms or behaviors (e.g., pain severity, craving). <ovid:br/>Method: We conducted a secondary analysis of a clinical trial examining the feasibility, acceptability, and preliminary effectiveness of a 4-week CBM adjunct for veterans (N = 28) receiving medication treatment for opioid use disorder (mOUD) with moderate pain for the past 3 months. We examined CBM effects versus control on pain severity, interference, and catastrophizing, as well as opioid craving and withdrawal. <ovid:br/>Results: CBM for opioid and pain cues did not correspond with changes in the primary clinical outcomes of opioid craving and pain intensity (ps > .111). Additional analyses of other possible outcomes, including pain interference, pain catastrophizing, and subjective opioid withdrawal, were also not associated with CBM (ps > .125). <ovid:br/>Conclusions: Results from this pilot study did not show changes in pain severity or opioid craving corresponding to CBM for opioid and pain. Findings should be considered preliminary given our small sample size; however, findings indicate a distinction between attentional biases, their modification, and clinically salient outcomes. Future research should examine CBM in larger, more diverse samples and assess the impacts of addiction severity, substance type, naturalistic settings, and more engaging methodologies (e.g., gamification of CBM tasks, using gaze-contingent paradigms). (PsycInfo Database Record (c) 2026 APA, […]
- Brain signatures of nociplastic pain: Fibromyalgia index and descending modulation at population level.on 4 mai 2026
Author Names: Kelleher, Eoin Maurice,Lange, Frederik,Wanigasekera, Vishvarani,Rathod-Mistry, Trishna,Nichols, Thomas,Seymour, Ben,Tracey, Irene,Segerdahl, Andrew Reilly,Irani, Anushka Database Source: APA PsycInfo <April 2026 Week 4> Journal Title: Brain: A Journal of Neurology Article Title: Brain signatures of nociplastic pain: Fibromyalgia index and descending modulation at population level. Year: 2026 Issue: 4 Volume: 149 Abstract: Nociplastic pain is defined by altered nociceptive processing in the absence of clear peripheral damage or somatosensory lesions. The Fibromyalgia Index (FMI), derived from the 2016 diagnostic criteria, is increasingly used as a marker of nociplastic pain severity in clinical studies, yet its neurobiological validity remains untested at scale. Using multimodal neuroimaging data from over 40 000 participants in UK Biobank, we examined whether FMI scores were associated with altered functional and structural connectivity within the descending pain modulatory system (DPMS), a brain network involved in endogenous pain control and implicated in nociplastic pain conditions. Functional connectivity was assessed using resting-state functional MRI (rfMRI), and structural connectivity using diffusion-weighted MRI (dMRI) tractography. Connectivity was quantified between seven DPMS regions: periaqueductal grey (PAG), rostral ventromedial medulla (RVM), hypothalamus, amygdala, rostral and subgenual anterior cingulate cortex (rACC, sgACC), and dorsolateral prefrontal cortex (dlPFC). Multi-group structural equation models tested associations between FMI scores and connectivity, stratified by chronic pain status. Mediation models evaluated which aspects of nociplastic pain accounted for the observed associations: widespread pain and SPACE symptoms (sleep disturbance, pain, affect, cognitive problems, and low energy). To assess specificity, we repeated analyses using the Douleur Neuropathique 4 (DN4), a measure of neuropathic pain, and average pain intensity as comparison outcomes. In 22 139 individuals with chronic pain (58% female; mean age 64.8, standard deviation 7.59), FMI scores were associated with altered structural connectivity between the PAG and amygdala [beta = 0.023, 95% confidence interval (CI): 0.0087 to 0.039; Pcorr = 0.0125] and […]
- Chronic pain assessment and treatment strategies for older adults.on 4 mai 2026
Author Names: Serdarevic, Mirsad Database Source: APA PsycInfo <April 2026 Week 4> Journal Title: Journal of Health Service Psychology: An Official Journal of the National Register of Health Service Psychologists Article Title: Chronic pain assessment and treatment strategies for older adults. Year: 2026 Issue: Volume: Abstract: Chronic pain is highly prevalent among older adults and contributes to disability, psychological distress, social isolation, and increased healthcare utilization. Older adults remain vulnerable to underassessment and undertreatment due to diagnostic complexity, comorbidity burden, polypharmacy, and limited access to behavioral health services. This article provides an applied overview of evidence-based assessment and intervention strategies for chronic pain among older adults within health service psychology settings. Using a clinical vignette to frame common presentation patterns, key diagnostic considerations and best practices in biopsychosocial pain assessment are reviewed, alongside integrated behavioral interventions such as CBT for chronic pain, ACT, mindfulness-based approaches, behavioral activation, and graded activity pacing. Clinical and ethical challenges-including autonomy/beneficence balance, opioid-related risk, and access inequities-are discussed. Practical recommendations for interdisciplinary collaboration and outcome monitoring are offered to support functional restoration and quality of life in later adulthood. (PsycInfo Database Record (c) 2026 APA, all rights reserved)
- An interpretative phenomenological analysis of the lived experiences of receiving cognitive behavioural therapy interventions for chronic pain by individuals living with chronic primary pain conditions.on 4 mai 2026
Author Names: Gore, Christina Database Source: APA PsycInfo <April 2026 Week 4> Journal Title: Dissertation Abstracts International: Section B: The Sciences and Engineering Article Title: An interpretative phenomenological analysis of the lived experiences of receiving cognitive behavioural therapy interventions for chronic pain by individuals living with chronic primary pain conditions. Year: 2026 Issue: 8-B Volume: 87 Abstract: Background Chronic Pain is a debilitating condition affecting billions worldwide with devastating consequences for the individual with chronic pain and those around them. Chronic Pain can be experienced as part of an underlying condition such as cancer (chronic secondary pain) or as 'a disease' in its own right (chronic primary pain). With chronic pain being a dynamic interplay between biological, social, and psychological factors, it is imperative for psychological treatments to be adequate in meeting the psychological needs of individuals with chronic pain. To date, Cognitive Behavioural Therapy (CBT) is the most commonly offered form of psychological therapy for chronic pain. This thesis sought to investigate how CBT interventions making up CBT treatment packages for chronic pain were experienced by participants with chronic primary pain conditions. Method An Interpretative Phenomenological Analytical approach was chosen as the most suitable theoretical framework aligned to the aims of this thesis. Seven participants who were living with chronic primary pain conditions based on the ICD-11 classifications and had received CBT treatment for chronic pain were recruited for participation. Through semi-structured interviews, participants shared their experiences of each CBT intervention making up their course of treatment. In keeping with IPA methodology, a case-by-case idiographic analysis was conducted followed by cross cases analysis. Findings Five CBT interventions for chronic pain were identified within the data set. Participants shared their experiences of 1) Behavioural Activation, also known as activity scheduling, 2) Problem Solving, 3) Graded Exposure, 4) Thought Challenging and 5) Pacing. Five Group Experiential Themes (GETs) representing participants' subjective experiences of these CBT interventions were developed. The first, […]
Pédiatrie
- Exercise testing in a paediatric chronic pain cohort - A cross-sectional observation studyon 4 mai 2026
Br J Pain. 2026 Apr 29:20494637261445408. doi: 10.1177/20494637261445408. Online ahead of print.ABSTRACTBACKGROUND: The utility of exercise testing in an interdisciplinary paediatric chronic pain assessment is unknown. The aims of this study were to explore exercise testing results in a paediatric chronic pain cohort and associations with baseline patient-reported outcome measures (PROMs), including various measures of pain experience and functioning.METHODS: There were 153 participants, aged 6-17 years, attending the Sydney Children's Hospital Interdisciplinary Chronic and Complex Pain Clinic with data analysed retrospectively. Exercise tests included the six-minute walk test (6MWT), plank, prone extension and pushups. Results were described and stratified by age, and Spearmen correlation coefficients (r s) were determined between baseline exercise testing results and PROMs, and between different exercise tests.RESULTS: The 6MWT distances were greater in the younger subgroup, however, there were no other differences in exercise tests between age groups. Associations between baseline exercise testing results and baseline PROMs ranged from very weak to moderate (r s's = .18-.40). Associations between different exercise testing results ranged from very weak to moderate (r s's = .17-.52). The 6MWT, plank and pushups each had at least five weak to moderate associations with PROMs and the prone extension test had one weak association.CONCLUSIONS: Exercise testing results in a paediatric chronic pain cohort are presented, including with age stratification. The results of the current study suggest that exercise testing provides unique information to supplement other forms of assessment. There is a need for standardised exercise protocols with normative datasets, so that clinical and research findings are more comparable across settings.PMID:42079779 | PMC:PMC13128793 | DOI:10.1177/20494637261445408
- Group-based psychological interventions for autistic youth with chronic pain: Narrative review and practice considerations for intensive interdisciplinary pediatric pain treatment.on 4 mai 2026
Author Names: Warner, Jacqueline N,Sim, Leslie A,Hatley-Cotter, Allison,Long, Janette,Weiss, Karen,Vater, Lindsey,Iacobone, Rocco,Black, William R Database Source: APA PsycInfo <April 2026 Week 3> Journal Title: Journal of Clinical Psychology in Medical Settings Article Title: Group-based psychological interventions for autistic youth with chronic pain: Narrative review and practice considerations for intensive interdisciplinary pediatric pain treatment. Year: 2026 Issue: Volume: Abstract: Emerging work characterizing youth with chronic pain increasingly recognizes a large cohort of youth with co-occurring chronic pain and autism. This development has prompted questions about how to adapt Intensive Interdisciplinary Pediatric Pain Treatment (IIPTs) and the group-based treatments commonly used in these settings to improve accessibility, acceptability, and utility for autistic participants. There is a need for clinically oriented literature that IIPT programs and clinical trialists can use to guide adaptation efforts. Given long-term risks of inadequately treated pediatric pain, we argue it is clinically and ethically important to identify reasonable autism-informed adjustments within existing IIPT frameworks, even as more empirical work unfolds to inform nuance. In this narrative review, we synthesize evidence from pediatric pain psychology and autism intervention literatures to identify overlapping mechanisms and opportunities for adaptation, with a specific focus on group-based CBT/ACT-oriented treatments delivered in IIPTs. We summarize emerging clinical characteristics of autistic adolescents enrolled in IIPTs, bridge autism and pediatric pain group treatment literature, map that literature onto pediatric pain targets and autism-informed IIPT group design considerations and provide practical examples of IIPT group modifications extended from the existing data and the authors' clinical experience delivering group-based pain psychology services to autistic youth in IIPTs. We also highlight constraints of group formats for autistic youth and emphasize flexible pathways of care. (PsycInfo Database Record (c) 2026 APA, all rights reserved)
- I-STRONG: An integrative, multicomponent treatment approach for chronic pain in pediatric sickle cell diseaseon 4 mai 2026
Blood Adv. 2026 Apr 23:bloodadvances.2025018952. doi: 10.1182/bloodadvances.2025018952. Online ahead of print.ABSTRACTChronic pain affects about 20% of adolescents living with sickle cell disease (SCD). There is a critical unmet need for evidence-based interdisciplinary approaches for chronic SCD pain treatment. We aimed to: 1) utilize community engagement to adapt an integrative multicomponent treatment program designed to meet the unique needs of chronic SCD pain (i.e., I-STRONG for SCD), and 2) optimize feasibility and acceptability of I-STRONG through a proof-of-concept trial. Modifications to an existing cognitive-behavioral therapy (CBT) and neuromuscular treatment program for chronic widespread pain were informed by semi-structured qualitative interviews with adolescents (12-18 years old) with chronic SCD pain (n = 12) and their caregivers (n = 12), community advisory boards, and interdisciplinary experts to develop I-STRONG. I-STRONG is a virtual 8-week, 16-session, group intervention combining CBT and neuromuscular exercise training, co-led by experts in psychology and physical therapy. A pilot clinical trial of I-STRONG (n = 12 adolescents; n = 9 caregivers) was conducted to iteratively optimize intervention feasibility and acceptability. Community engagement strategies informed systematic adaptations for access, engagement, relevance, satisfaction, and sense of belonging to meet the unique needs of youth experiencing chronic SCD pain. Pilot testing demonstrated high levels of feasibility (95% completion, 97% intervention fidelity, 92% retention), moderate to high acceptability, and safety. Over 82% of adolescents reported improvements in pain at post-treatment and 3-month follow-up. Preliminary evidence suggests that I-STRONG is a promising approach for management of chronic pain in pediatric SCD. A planned multi-center, randomized controlled trial will evaluate I-STRONG's efficacy for pain reduction. NCT06110754.PMID:42024471 | DOI:10.1182/bloodadvances.2025018952
- Psychological, behavioral, cognitive and social factors associated with single vs dual alcohol and cannabis use in adolescents with chronic painon 4 mai 2026
Addict Behav. 2026 Apr 7;179:108704. doi: 10.1016/j.addbeh.2026.108704. Online ahead of print.ABSTRACTPURPOSE: Alcohol and cannabis are psychotropic substances most used by adolescents. Psychological, behavioral, social, and cognitive factors linked to substance use in adolescents with chronic pain (ACP) are unclear. We examined these factors among four groups: those reporting Only Alcohol Use (AU), Only Cannabis Use (CU), Co-use of Alcohol and Cannabis (CAM), and No Substance Use (No-SU).METHODS: From September 2021 to May 2024, we surveyed 243 patients from a pediatric pain clinic in the Northeastern U.S. Kruskal Wallis, Mann-Whitney U, and Monte Carlo Chi-Square tests assessed group differences.RESULTS: Among 243 (Mage = 16.9, SD = 1.42 years, 68% female), 12.3% reported AU, 5.3% CU, 19.8% CAM, and 62.6% No-SU in their lifetime. Groups differed by age, functional disability, depressive symptoms, and behavior avoidance in drive and fun-seeking domains (ps < 0.05). CAM group was older (p < 0.001), more depressed (p = 0.003), stressed (p = 0.03), and had more school-related anxious anticipation (p = 0.03) than No-SU, reporting more drinking and drunkenness (ps < 0.05) than AU. CU group reported greater pain interference (p = 0.04) and functional disability (p = 0.01) than AU, with 100% using for symptom relief and 85.6% for pain. Increased drunkenness past-year was positively associated with stricter curfew times and increased parental supervision in the CAM group (p < 0.006).DISCUSSION: CAM group reported more stress, depression, and alcohol consumption, complicating pain management. CU is frequently used for pain relief and is associated with greater functional disability. Interventions targeting substance use and mental, physical, and social wellbeing in ACP are limited, underscoring the need for multidisciplinary strategies addressing pain and substance use in parallel.PMID:41990709 | DOI:10.1016/j.addbeh.2026.108704
- A pilot implementation study of a chronic pain core outcome set and decision tree for children and young people with cerebral palsy.on 4 mai 2026
Disability & Rehabilitation; 04/15/2026Purpose: This study aimed to (i) develop a decision tree to guide clinicians to use a core outcome set (COS) of chronic pain assessment tools specific to children and young people with cerebral palsy and (ii) pilot test the implementation of the decision tree and core set in clinical practice. Materials and methods: The study involved two stages. Stage one was the development of the decision tree using a focus group with clinicians. Stage two implemented the decision tree and COS in one rehabilitation service over three months. Evaluation involved an online survey with clinicians (physiotherapists, occupational therapists, nurses and doctors). The Capability, Opportunity, Motivation-Behaviour model was used to guide qualitative analysis of survey responses and identify barriers and enablers to use of the decision tree. Results: Eight clinicians participated, completing 103 pain assessments on 82 children during the implementation period. All clinicians reported increased knowledge and confidence after using the decision tree (capability) and ease of access to assessment tools (opportunity) as primary enablers to assessing pain in the clinic. Lack of time for pain assessment was the most common barrier reported. Conclusion: The decision tree showed promise in assisting clinicians to include pain assessment in clinical care. IMPLICATIONS FOR REHABILITATION: Clinician knowledge of chronic pain assessment tools and lack of time were key barriers to psychosocial chronic pain assessment in clinical practice. The decision tree enhanced clinician capability in selecting appropriate chronic pain assessment tools. Strategies like pre-appointment action planning and utilisation of waiting-room time were identified strategies to improve efficiency in clinical practice. A scaled-up implementation study is required to ensure sustained and broader use of chronic pain assessment tools in rehabilitation.(AN 192981897); ISSN: 09638288CINAHL Complete
- Chronic pain negatively affects children's outcomes on the English Standardised Assessment Tests (SAT).on 4 mai 2026
Journal of Health Psychology; 05/01/2026Chronic pain is believed to have substantial negative effects on children's school outcomes. However, there is currently no research regarding the impact of chronic pain on children in England. Educational differences between countries may mean the impact of chronic pain cannot be generalised between countries, indicating the need for a study in England exploring this relationship. The current cross-sectional study collected scores for Standardised Assessment Tests (SAT), attendance rates, and mental health data from 148 parents of children with and without chronic pain aged 11–14 years via an online survey. Results show children with chronic pain scored lower on the SATs, had higher absence rates, and poorer mental health than children without chronic pain after controlling for gender, SES and SEND. These findings have implications for the education system in how to support children with chronic pain to achieve their educational potential.(AN 192936995); ISSN: 13591053CINAHL Complete
- Paediatric long-term home respiratory support: Recommendations of the Swiss Society of Paediatric Pulmonologyon 4 mai 2026
Respiration. 2026 Apr 10:1-37. doi: 10.1159/000550985. Online ahead of print.ABSTRACTThe number of paediatric patients evaluated for long-term home respiratory support has risen sharply in recent years, reflecting both improved survival of children with complex chronic conditions and expanded therapeutic indications. This population is characterized by substantial clinical heterogeneity, encompassing obstructive, restrictive, or central ventilatory disorders. Contributing comorbidities-such as severe obesity, chronic aspiration with secondary lung disease, neuromuscular weakness, impaired central respiratory drive, and dynamic upper-airway obstruction-further complicate diagnostic assessment and long-term management. This consensus statement, developed by the Special Interest Group of the Swiss Society of Paediatric Pulmonology provides comprehensive recommendations for Switzerland. It defines current indications for non-invasive and invasive home respiratory support, proposes criteria for patient selection, and outlines key competencies and composition of an optimal multidisciplinary care team. The document also specifies requirements for equipment provision, safety measures, and training of caregivers, while offering structured guidance for monitoring strategies, long-term follow-up, and management of acute exacerbations. Ethical considerations and best practices for transitioning adolescents to adult respiratory care are additionally addressed, with the aim of standardizing care pathways and improving clinical outcomes.PMID:41961760 | DOI:10.1159/000550985


